Dietary fat and fatty foods in the prevention of non-communicable diseases: A review of the evidence

被引:14
|
作者
Schwingshackl, Lukas [1 ,4 ]
Heseker, Helmut [2 ]
Kiesswetter, Eva [1 ]
Koletzko, Berthold [3 ]
机构
[1] Univ Freiburg, Inst Evidence Med, Fac Med, Freiburg, Germany
[2] Paderborn Univ, Dept Sports & Hlth, Paderborn, Germany
[3] LMU Ludwig Maximilians Univ Munich, Univ Munich, Dr von Hauner Childrens Hosp, Dept Paediat,Med Ctr, Munich, Germany
[4] Breisacher Str 86, D-79110 Freiburg, Germany
关键词
Evidence; Dietary fat; Fat quality; Fatty foods; Systematic reviews; Health outcomes; CORONARY-HEART-DISEASE; DOSE-RESPONSE METAANALYSIS; RANDOMIZED CONTROLLED-TRIALS; CARDIOVASCULAR RISK-FACTORS; CANCER-RISK; ENDOMETRIAL CANCER; MEDITERRANEAN DIET; PROSPECTIVE COHORT; BREAST-CANCER; ACIDS INTAKE;
D O I
10.1016/j.tifs.2022.08.002
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Background: Reducing the intake of total fat, saturated fatty acids (SFA) and dietary cholesterol was a cornerstone of dietary guidance in past decades. This emphasis shifted recently from lowering the intake of total fat to focusing on the quality of dietary fat intake, the avoidance of industrial trans-fatty acids (TFA), and the sub-stitution of SFA with unsaturated fatty acids. There is also a trend towards investigating diet-disease associations of fatty foods rather than nutrients. Scope and approach: We aimed to summarize comprehensively the currently available evidence for total dietary fat, fat quality, and fatty foods such as butter, vegetable oils, nuts and seeds on risk of non-communicable dis-eases including cardiovascular disease (and its risk factors), cancer, type 2 diabetes, and neurodegenerative diseases. Key findings and conclusions: The findings from systematic reviews of prospective observational studies, which often compared extreme intake categories, found mainly no association of total fat, monounsaturated fatty acids (MUFA), polyunsaturated fatty acids (PUFA), and SFA with risk of non-communicable diseases. Systematic re-views of randomized controlled trials indicate that SFA and/or TFA substitution with MUFA and/or PUFA im-proves blood lipids and markers of glycemic control (observed only for SFA replacement), with the effect of PUFA being more pronounced. A higher intake of total TFA was associated increased risk of cardiovascular disease. In line with current dietary guidelines, the available published evidence deems it reasonable to recommend replacement of SFA with MUFA and PUFA and avoidance of consumption of industrial TFA.
引用
收藏
页码:173 / 184
页数:12
相关论文
共 50 条
  • [41] The use of mobile health applications for the prevention of non-communicable diseases
    Zangger, Martina
    Walchli, Cornelia
    Stefenelli, Ulrich
    Stute, Petra
    HEALTH AND TECHNOLOGY, 2021, 11 (03) : 585 - 593
  • [42] Prevention and control of non-communicable diseases in iran: the case for Investment
    Mahmood Yousefi
    Ilker Dastan
    Farbod Alinezhad
    Mansour Ranjbar
    Christoph Hamelmann
    Afshin Ostovar
    Alireza Moghisi
    Sima Mohammadi
    Awad Mataria
    Asmus Hammerich
    Slim Slama
    Nasim Pourghazian
    Alireza Mahdavi Hezaveh
    Behzad Valizadeh
    Parisa Torabi
    Mehdi Najmi
    Mohammad Moradi
    Alieh Hodjatzadeh
    Fatemeh Keshvari-Shad
    BMC Public Health, 22
  • [43] Sleep: a serious contender for the prevention of obesity and non-communicable diseases
    Rae, Dale E.
    Ebrahim, Irshaad
    Roden, Laura C.
    JOURNAL OF ENDOCRINOLOGY METABOLISM AND DIABETES OF SOUTH AFRICA, 2016, 21 (01) : 1 - +
  • [44] The midwife's role in prevention of non-communicable diseases in Iran
    Abedi, Parvin
    Khosravi, Shahla
    Mirghafourvand, Mojgan
    Tabrizi, Jafar Sadegh
    JOURNAL OF EDUCATION AND HEALTH PROMOTION, 2021, 10 (01)
  • [45] Prevention of non-communicable chronic Diseases through "healthy" Nutrition
    Bosy-Westphal, Anja
    Mueller, Manfred J.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2021, 146 (06) : 389 - 397
  • [46] Task-sharing for the prevention and control of non-communicable diseases
    Joshi, Rohina
    Peiris, David
    LANCET GLOBAL HEALTH, 2019, 7 (06): : E686 - E687
  • [47] Prevention and control of non-communicable diseases in iran: the case for Investment
    Yousefi, Mahmood
    Dastan, Ilker
    Alinezhad, Farbod
    Ranjbar, Mansour
    Hamelmann, Christoph
    Ostovar, Afshin
    Moghisi, Alireza
    Mohammadi, Sima
    Mataria, Awad
    Hammerich, Asmus
    Slama, Slim
    Pourghazian, Nasim
    Hezaveh, Alireza Mahdavi
    Valizadeh, Behzad
    Torabi, Parisa
    Najmi, Mehdi
    Moradi, Mohammad
    Hodjatzadeh, Alieh
    Keshvari-Shad, Fatemeh
    BMC PUBLIC HEALTH, 2022, 22 (01)
  • [48] Sustainability in medicine: a case for the prevention of chronic non-communicable diseases
    Gerdi Weidner
    The Environmentalist, 2012, 32 (3): : 353 - 359
  • [49] Trends in Policy on the Prevention and Control of Non-Communicable Diseases in Japan
    Ezoe, Satoshi
    Noda, Hiroyuki
    Akahane, Naoki
    Sato, Osamu
    Hama, Takashi
    Miyata, Tatsunori
    Terahara, Tomohiro
    Fujishita, Manami
    Sakamoto, Haruka
    Abe, Sarah Krull
    Gilmour, Stuart
    Shobayashi, Tokuaki
    HEALTH SYSTEMS & REFORM, 2017, 3 (04) : 268 - 277
  • [50] Non-communicable diseases and maternal health: a scoping review
    Tabassum Firoz
    Beth Pineles
    Nishika Navrange
    Alyssa Grimshaw
    Olufemi Oladapo
    Doris Chou
    BMC Pregnancy and Childbirth, 22